Hemopoiesis
Title
Date Published
Novel thrombopoietic agents.
June 30, 2007
Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects.
June 30, 2007
Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
June 29, 2007
Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery.
June 13, 2007
Effect of recombinant human interleukin 11 on the platelet after hematopoietic stem cell transplantation in patients with leukemia.
June 1, 2007
Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist.
June 1, 2007
Oxygen breathing may be a cheaper and safer alternative to exogenous erythropoietin (EPO).
May 8, 2007
Pre-operative oral iron supplementation reduces blood transfusion in colorectal surgery – a prospective, randomised, controlled trial.
May 1, 2007
Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.
April 23, 2007
Erythropoietin and iron-restricted erythropoiesis.
April 1, 2007
Functional iron deficiency in hemodialysis patients with high ferritin.
April 1, 2007
Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness.
April 1, 2007
Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement.
April 1, 2007
Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy.
March 6, 2007
A randomized trial comparing immediate versus delayed treatment of anemia with once-weekly epoetin alfa in patients with non-small cell lung cancer scheduled to receive first-line chemotherapy.
March 1, 2007
Phase II study of three dose levels of continuous erythropoietin receptor activator (C.E.R.A.) in anaemic patients with aggressive non-Hodgkin’s lymphoma receiving combination chemotherapy.
March 1, 2007
Phase I clinical study of eltrombopag, an oral, non- peptide thrombopoietin receptor agonist.
February 27, 2007
Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma.
February 14, 2007
New thrombopoietic growth factors.
February 8, 2007
Speed of haemoglobin response in patients with cancer: a review of the erythropoietic proteins.
February 3, 2007